Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Molecular Tumor Board, Early Drug Development

Jordi Rodon

MD, PhD

🏢MD Anderson Cancer Center🌐USA

Professor, Investigational Cancer Therapeutics

58
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Jordi Rodon is a precision oncology leader who has conducted pivotal early-phase basket trials at MD Anderson and previously in Barcelona. He was a principal investigator of the DRUP trial (Drug Rediscovery Protocol) in the Netherlands, which systematically evaluated off-label targeted therapy guided by molecular profiling. His work on ESMO ESCAT actionability tiers and variant of uncertain significance interpretation has helped standardize molecular tumor board practice.

Share:

🧪Research Fields 研究领域

early phase trials molecular tumor board
PI3K pathway basket trials
DRUP trial tumor agnostic
phase I trial design precision
VUS variant of uncertain significance management

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Jordi Rodon 的研究动态

Follow Jordi Rodon's research updates

留下邮箱,当我们发布与 Jordi Rodon(MD Anderson Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment